SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA for HORIZON THERAPEUTICS (F/K/A) HORIZON PHARMA USA INC

Pharmacy PHA

Tax reform, intellectual property and trade related to client's products, generally; Orphan Drug Act; HRSA interim final rule RIN 0906-AA89, 340B drug pricing and general pharmaceutical issues; Interest deductions; Proposed Executive Order on pharmaceuticals and patient access;

Foreign entity interest: Lobbying is done on-behalf of a US-domestic entity with a foreign parent, Horizon Pharma plc. Any lobbying efforts tangentially affect the foreign parent who has an interest in the success of its domestic entity.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Commerce, Dept of (DOC)